Reduce Hands-On Time to Rapidly Accelerate Bulk Proteomic Insights
In an upcoming virtual event with Clinical Lab Manager on Wednesday, December 9th, we are excited to feature our groundbreaking high-plex walk-away immunoassays. This application allows users to completely automate their bulk proteomics workflows by decentralizing multiplexed and fully automated functional proteomics for accelerated insights. IsoPlexis’ re-engineered ELISA technology is packaged in a fully automated benchtop system with a small footprint and end-to-end automation to widen access to advanced insights. The high-plex automated immunoassay application allows users to identify 20-30 cytokines in bulk using only 11 µL of sample per chip and with only 5 minutes of hands-on sample prep time.
Sean Mackay, IsoPlexis’ Co-Founder & CEO, will cover the following topics in this virtual event:
- How high-plex automated immunoassays were utilized in multiple high-impact studies to characterize inflammatory markers of neurological symptoms of COVID-19 in BMC Neurology and Cell.
- How this solution helped researchers discover metastasis initiators to develop a potential therapy to improve patient outcomes.
- How high-plex automated immunoassays facilitate critical discoveries in immune medicine.
- How this application is accelerating the development of advanced therapeutics across disciplines like cellular regenerative medicine, cancer immunology, infectious disease, and inflammation.
This virtual event will take place on Wednesday, December 9th, 2020, at 12:30 PM EST. Register here to join our mission to enable fast highly multiplexed proteomics for accelerated insights accessible to every lab worldwide.